• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » St. Jude Medical closes Q4, 2010 on a roll

St. Jude Medical closes Q4, 2010 on a roll

January 26, 2011 By MassDevice staff

STJ logo

St. Jude Medical Inc. (NYSE:STJ) wrapped up 2010 and put a bow on it with near-double-digit boosts to its top and bottom lines.

The St. Paul, Minn.-based medical device maker’s fourth-quarter profits rose 8.9 percent to $206.4 million, or 62 cents per diluted share, on sales of $1.35 billion during the three months ended Jan. 1. That compared with profits of $189.7 million, or 57 cents per diluted share, on sales of $1.20 billion during Q4 2009.

The improves further once charges related to recent acquisitions are taken into account. Adjusted for acquisition costs from the buyouts of LightLab Imaging Inc. and AGA Medical, the settlement of a U.S. Justice Dept. probe, a charge on extra implantable cardiac defibrillator inventory and a tax benefit from a federal R&D credit, Q4 net income was $251.1 million, or 75 cents per adjusted, diluted share — up more than 17 percent over Q3 2009.

Chairman, president and CEO Daniel Stark said the company posted the strong results despite "difficult macro-economic challenges."

Here’s a breakdown of how each STJ segment fared during the fourth quarter and 2010, compared with the same period in 2009:

  Q4 % increase 2010 % increase
Cardiac Rhythm Management
ICDs $458 million 16% $1.82 billion 15%
Pacemakers $304 million flat $708 million 13%
TOTAL $762 million 9% $3.04 billion 10%
Cardiovascular
Vascular closure $92 million -2% $375 million -2%
Heart valves $87 million 10% $337 million 4%
TOTAL $287 million* 20% $1.04 billion 9%
Atrial Fibrillation $193 million 13% $708 million 13%
Neuromodulation $108 million 15% $380 million 15%
*Includes a $25 million assist from AGA Medical.

St. Jude said it expects adjusted, consolidated Q1 net earnings in the range of 77 cents to 79 cents per; full-year adjusted, consolidated EPS are forecast to be between $3.25 and $3.30

STJ shares were down 2 percent to $41.76 in mid-morning activity.

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well Tagged With: stjudemedical

More recent news

  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy
  • Elucent Medical wins FDA breakthrough nod for in-body spatial intelligence system
  • EndoQuest Robotics completes first cases in pivotal surgical robot trial
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
  • Intuitive Surgical is making a CEO change

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy